The high cost of implantable defibrillators | Zendy

Mark A. Hlatky | Zendy; Daniel B. Mark | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The high cost of implantable defibrillators

Author(s) -

Mark A. Hlatky,

Daniel B. Mark

Publication year - 2006

Publication title -

european heart journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.336

H-Index - 293

eISSN - 1522-9645

pISSN - 0195-668X

DOI - 10.1093/eurheartj/ehl311

Subject(s) - medicine , life expectancy , economic shortage , randomized controlled trial , health care , intensive care medicine , cardiac resynchronization therapy , emergency medicine , medical emergency , cardiology , heart failure , population , government (linguistics) , environmental health , ejection fraction , economics , economic growth , linguistics , philosophy

Increased use of ICDs in patients with cardiac disease has the potential to strain national health care budgets because of the large numbers of eligible patients and the high cost of the ICDs. Randomized trials show ICDs increase life-expectancy in some groups of patients and also increase total medical costs significantly. ICDs exemplify the role of new technology as the main force behind rising health care costs. ICDs have not been used in all eligible patients, in part because of cost, but also because of patient resistance and a shortage of specialists able to implant and manage complex ICDs. The cost-effectiveness of ICDs would be improved by development of simpler and cheaper devices, and by better tools to identify patients who benefit from an ICD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research